Literature DB >> 22771272

Efficacy of rituximab in dermatomyositis and polymyositis refractory to conventional therapy.

Simón Ángel Sánchez-Fernández1, José Antonio Carrasco Fernández, Luisa Marena Rojas Vargas.   

Abstract

We report one case of dermatomyositis and one of polymyositis refractory to several conventional inmunosupressive therapies, which present a response after treatment with rituximab, enabling steroid dose reduction and a prolonged remission.
Copyright © 2012 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771272     DOI: 10.1016/j.reuma.2012.02.007

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  2 in total

1.  Immune-mediated necrotising myopathy associated with antibodies to the signal recognition particle treated with a combination of rituximab and cyclophosphamide.

Authors:  Marisa Fernandes das Neves; Joana Caetano; Susana Oliveira; José Delgado Alves
Journal:  BMJ Case Rep       Date:  2015-08-03

Review 2.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.